Gsk.com - Home | GSK US

Provided by Alexa ranking, gsk.com has ranked N/A in N/A and 2,609,373 on the world. gsk.com reaches roughly 1,191 users per day and delivers about 35,734 users each month. The domain gsk.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 34.117.83.221 and it is a .com domain.

WEBPress releases. April 08 2024 ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV. March 20 2024 GSK announces cap of $35 per month on U.S. patient out-of-pocket costs for its entire portfolio of asthma and COPD inhalers.

List of domain same IP 34.117.83.221

Search Results related to gsk.com on Search Engine

Home | GSK US
gsk.com

https://us.gsk.com/en-us/home/

WEBPress releases. April 08 2024 ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV. March 20 2024 GSK announces cap of $35 per month on U.S. patient out-of-pocket costs for its entire portfolio of asthma and COPD inhalers.

DA: 23 PA: 61 MOZ Rank: 57

Home | GSK
gsk.com

https://www.gsk.com/en-gb/

WEBWe are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

DA: 99 PA: 49 MOZ Rank: 86

GSK plc - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/GSK_plc

WEBGSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.

DA: 25 PA: 81 MOZ Rank: 97

Careers | GSK US
gsk.com

https://us.gsk.com/en-us/careers/

WEBAt GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

DA: 10 PA: 92 MOZ Rank: 2

Company | GSK
gsk.com

https://www.gsk.com/en-gb/company/

WEBWe are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.

DA: 26 PA: 30 MOZ Rank: 90

GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/GSK/

WEB30.59. -1.20%. Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

DA: 89 PA: 43 MOZ Rank: 84

Company | GSK US
gsk.com

https://us.gsk.com/en-us/company/

WEBAt a glance. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.

DA: 45 PA: 56 MOZ Rank: 18

At a glance | GSK US
gsk.com

https://us.gsk.com/en-us/company/at-a-glance/

WEBGlobally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and …

DA: 26 PA: 22 MOZ Rank: 16

GSK at a glance | GSK
gsk.com

https://www.gsk.com/en-gb/company/gsk-at-a-glance/

WEBWe are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease. Download.

DA: 100 PA: 98 MOZ Rank: 20

GlaxoSmithKline Pharmaceuticals - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/GlaxoSmithKline_Pharmaceuticals

WEBGlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines.

DA: 87 PA: 20 MOZ Rank: 90

Alexa Rank

GLOBAL RANK

2,609,373

Alexa Reach

0.0000525818

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

1,191

Monthly Unique Visitors

35,734

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

7,644

Indonesia

5,978

Taiwan

1,944

United Kingdom

1,726

Brazil

1,562

Nigeria

1,365

Egypt

1,147

Hong Kong

1,083

Canada

1,083

Australia

943

Philippines

675

India

658

Malaysia

647

Spain

536

Germany

522

Mexico

500

France

472

Italy

436

Turkey

400

Iraq

364

Thailand

357

Netherlands

343

Israel

339

Cambodia

282

Algeria

218

Ireland

197

Romania

189

Jordan

175

Poland

168

Ghana

161

Argentina

154

South Africa

139

Belgium

125

Czechia

114

Ukraine

107

Japan

107

Morocco

104

South Korea

100

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
gsk.com	A	IN	120	Ip: 34.117.83.221
gsk.com	NS	IN	21600	Target: ns-1070.awsdns-05.org
gsk.com	NS	IN	21600	Target: ns-1601.awsdns-08.co.uk
gsk.com	NS	IN	21600	Target: ns-87.awsdns-10.com
gsk.com	NS	IN	21600	Target: ns-999.awsdns-60.net
gsk.com	SOA	IN	900	Mname: ns-999.awsdns-60.net Rname: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum-ttl: 86400
gsk.com	MX	IN	3600	Pri: 5 Target: mxa-001caa02.gslb.pphosted.com
gsk.com	MX	IN	3600	Pri: 5 Target: mxb-001caa02.gslb.pphosted.com
gsk.com	TXT	IN	60	Txt: /ZT+19PNJ/2m3OQQlu/JW4YRjiI= Entries_0: /ZT+19PNJ/2m3OQQlu/JW4YRjiI=
gsk.com	TXT	IN	60	Txt: 46314549aa271bd52a60e6c394471398a7daba94195caf7c0ad1a7fc747a8313 Entries_0: 46314549aa271bd52a60e6c394471398a7daba94195caf7c0ad1a7fc747a8313
gsk.com	TXT	IN	60	Txt: MS=ms52422680 Entries_0: MS=ms52422680
gsk.com	TXT	IN	60	Txt: ZOOM_verify_GmYSH5N2SsSVd5IiskLTtg Entries_0: ZOOM_verify_GmYSH5N2SsSVd5IiskLTtg
gsk.com	TXT	IN	60	Txt: _globalsign-domain-verification=YAlUiOIcLf2w_4JBXYS-cgwWWBpQPjQC4wL5YxrnTH Entries_0: _globalsign-domain-verification=YAlUiOIcLf2w_4JBXYS-cgwWWBpQPjQC4wL5YxrnTH
gsk.com	TXT	IN	60	Txt: adobe-idp-site-verification=1a542705d103b1b61fef7cfa8faae55aa98921c853154e0e55241aa0fc16158a Entries_0: adobe-idp-site-verification=1a542705d103b1b61fef7cfa8faae55aa98921c853154e0e55241aa0fc16158a
gsk.com	TXT	IN	60	Txt: airtable-verification=f0f7584a3a686e37af7211c43ba80d06 Entries_0: airtable-verification=f0f7584a3a686e37af7211c43ba80d06
gsk.com	TXT	IN	60	Txt: amazonses:R/oqH7QHdio+vXCeQ6jzKFaT8654S73t569K6CKZs6I= Entries_0: amazonses:R/oqH7QHdio+vXCeQ6jzKFaT8654S73t569K6CKZs6I=
gsk.com	TXT	IN	60	Txt: apple-domain-verification=hE2oLHsSZHDdGLLE Entries_0: apple-domain-verification=hE2oLHsSZHDdGLLE
gsk.com	TXT	IN	60	Txt: atlassian-domain-verification=l1Z8BYztMb8MijiuI8UIBmNYx3R9I8ZLs84apb6rXv/QCjpr4Yjwj2zBag9D2F4+ Entries_0: atlassian-domain-verification=l1Z8BYztMb8MijiuI8UIBmNYx3R9I8ZLs84apb6rXv/QCjpr4Yjwj2zBag9D2F4+
gsk.com	TXT	IN	60	Txt: atlassian-domain-verification=zdxihZXuWCS1onHmba6zHTL4mBi4q/6ec87WKUqW3bipKbmXHAw4jdnX4u3o0cmu Entries_0: atlassian-domain-verification=zdxihZXuWCS1onHmba6zHTL4mBi4q/6ec87WKUqW3bipKbmXHAw4jdnX4u3o0cmu
gsk.com	TXT	IN	60	Txt: bd52c1f6be714d6ebc2a9c139597fe3a Entries_0: bd52c1f6be714d6ebc2a9c139597fe3a
gsk.com	TXT	IN	60	Txt: box-domain-verification=470291b1b8c20979f609467654e79c9e0238084b7fd6b133ead14488fc3b8d26 Entries_0: box-domain-verification=470291b1b8c20979f609467654e79c9e0238084b7fd6b133ead14488fc3b8d26
gsk.com	TXT	IN	60	Txt: box-domain-verification=928a3c1f9c024a2c53599a76d1045f9c46e2b0f896e5939a970fdc29b2bd7991 Entries_0: box-domain-verification=928a3c1f9c024a2c53599a76d1045f9c46e2b0f896e5939a970fdc29b2bd7991
gsk.com	TXT	IN	60	Txt: docker-verification=1396de14-7a6f-4a3d-b579-429042390261 Entries_0: docker-verification=1396de14-7a6f-4a3d-b579-429042390261
gsk.com	TXT	IN	60	Txt: facebook-domain-verification=fepox61pkp4llceghsrvo9wbdu50y3 Entries_0: facebook-domain-verification=fepox61pkp4llceghsrvo9wbdu50y3
gsk.com	TXT	IN	60	Txt: facebook-domain-verification=s79fy8b705prth71j83ojr4yo7aahi Entries_0: facebook-domain-verification=s79fy8b705prth71j83ojr4yo7aahi
gsk.com	TXT	IN	60	Txt: facebook-domain-verification=xjk0szosgc4rjzr6q5tg7ct1qxv8ak Entries_0: facebook-domain-verification=xjk0szosgc4rjzr6q5tg7ct1qxv8ak
gsk.com	TXT	IN	60	Txt: gather-domain-verification=35662fc1-bcee-40a4-b7e1-42ecc944dc65 Entries_0: gather-domain-verification=35662fc1-bcee-40a4-b7e1-42ecc944dc65
gsk.com	TXT	IN	60	Txt: google-site-verification=FcHW0uDF1wXynfK2g0JiKiHeIp5V96mJk-N0B8U5cuc Entries_0: google-site-verification=FcHW0uDF1wXynfK2g0JiKiHeIp5V96mJk-N0B8U5cuc
gsk.com	TXT	IN	60	Txt: google-site-verification=FpGtSQEL_7Dqynv0zkgWaWJrMCRgrocNGlG7iq8jyoE Entries_0: google-site-verification=FpGtSQEL_7Dqynv0zkgWaWJrMCRgrocNGlG7iq8jyoE
gsk.com	TXT	IN	60	Txt: google-site-verification=RlJMNPbIJ3Qtx4t7sCrH7PeIRUcPio023L6RYPAbaBQ Entries_0: google-site-verification=RlJMNPbIJ3Qtx4t7sCrH7PeIRUcPio023L6RYPAbaBQ
gsk.com	TXT	IN	60	Txt: google-site-verification=Vo27n252DXp-qk_WuYlze_OCpQvgKAmdkpQ9pDZWKB4 Entries_0: google-site-verification=Vo27n252DXp-qk_WuYlze_OCpQvgKAmdkpQ9pDZWKB4
gsk.com	TXT	IN	60	Txt: google-site-verification=ZBRZsdsDYNKflXclgkWWMbWhxI6XxkcLmDnmxc1D6aE Entries_0: google-site-verification=ZBRZsdsDYNKflXclgkWWMbWhxI6XxkcLmDnmxc1D6aE
gsk.com	TXT	IN	60	Txt: google-site-verification=vA092sTjMxEH8IFhOFZ8XAigFW3zrAZZhczejf6CPpw Entries_0: google-site-verification=vA092sTjMxEH8IFhOFZ8XAigFW3zrAZZhczejf6CPpw
gsk.com	TXT	IN	60	Txt: onetrust-domain-verification=4eb96f2474644460a5a09efee893f232 Entries_0: onetrust-domain-verification=4eb96f2474644460a5a09efee893f232
gsk.com	TXT	IN	60	Txt: rhxplhd6jgwjqy4wty65v0h1swtqhnzt Entries_0: rhxplhd6jgwjqy4wty65v0h1swtqhnzt
gsk.com	TXT	IN	60	Txt: scq9sj3hqecv1t2dqckdtd20bg Entries_0: scq9sj3hqecv1t2dqckdtd20bg
gsk.com	TXT	IN	60	Txt: smartsheet-site-validation=0cQRK_ZUMaO-1J0URmGVc_ql0hS6q4Sk Entries_0: smartsheet-site-validation=0cQRK_ZUMaO-1J0URmGVc_ql0hS6q4Sk
gsk.com	TXT	IN	60	Txt: smartsheet-site-validation=foYOl-7T6FYOs-xlxgc1u_FuLjFIX9vc Entries_0: smartsheet-site-validation=foYOl-7T6FYOs-xlxgc1u_FuLjFIX9vc
gsk.com	TXT	IN	60	Txt: smartsheet-site-validation=ogQOvGH4Rs8ENz08bTpkM6RowzmrIgBS Entries_0: smartsheet-site-validation=ogQOvGH4Rs8ENz08bTpkM6RowzmrIgBS
gsk.com	TXT	IN	60	Txt: smartsheet-site-validation=sbiSUBaozvUVWD-AQ4DS9Amgye1KJkgl Entries_0: smartsheet-site-validation=sbiSUBaozvUVWD-AQ4DS9Amgye1KJkgl
gsk.com	TXT	IN	60	Txt: twilio-domain-verification=66002f7976ba22a0e3a7a8d201f6c81f Entries_0: twilio-domain-verification=66002f7976ba22a0e3a7a8d201f6c81f
gsk.com	TXT	IN	60	Txt: v=DKIM1; g=; k=rsa; p=MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCkNFyczmsiaWv1ohSXjmZljXE+zTg0ki0rxyvyQ8LG2l/5uCykMGRmDJpteHC+fiTRiHioD01dRxiHiVlTaYjj0PY/Yu3+GSFhLnvj1csllIbAK9ccOl6v80P5yV57p7Bc9+eW1RdyQhxPMUsOXnGQpcB9k7pTIJExH8FsD1t8iQIDAQAB Entries_0: v=DKIM1; g=; k=rsa; p=MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCkNFyczmsiaWv1ohSXjmZljXE+zTg0ki0rxyvyQ8LG2l/5uCykMGRmDJpteHC+fiTRiHioD01dRxiHiVlTaYjj0PY/Yu3+GSFhLnvj1csllIbAK9ccOl6v80P5yV57p7Bc9+eW1RdyQhxPMUsOXnGQpcB9k7pTIJExH8FsD1t8iQIDAQAB
gsk.com	TXT	IN	60	Txt: v=DKIM1; g=; k=rsa; p=MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDl3Ju9fsWggJqzUZfaEjMjYZiNBJOtC6tZ+UZnYHiNV8rWYvfH/qaOzwD9q8jivC7zk4GJuXh9cECd3MAb3sw+Qet10E5RkeLzDw+0zKecYQWKCXWSGKOeHDfyP9VqrlL2Bi1KieM8Q0KsFFwC5eoZqil/PwDhGlkFcNYae3TrWwIDAQAB Entries_0: v=DKIM1; g=; k=rsa; p=MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDl3Ju9fsWggJqzUZfaEjMjYZiNBJOtC6tZ+UZnYHiNV8rWYvfH/qaOzwD9q8jivC7zk4GJuXh9cECd3MAb3sw+Qet10E5RkeLzDw+0zKecYQWKCXWSGKOeHDfyP9VqrlL2Bi1KieM8Q0KsFFwC5eoZqil/PwDhGlkFcNYae3TrWwIDAQAB
gsk.com	TXT	IN	60	Txt: v=spf1 include:%{ir}.%{v}.%{d}.spf.has.pphosted.com ~all Entries_0: v=spf1 include:%{ir}.%{v}.%{d}.spf.has.pphosted.com ~all
gsk.com	TXT	IN	60	Txt: webexdomainverification.18AD=02d4c8a4-b214-447d-bcdb-51f7fe1e79d0 Entries_0: webexdomainverification.18AD=02d4c8a4-b214-447d-bcdb-51f7fe1e79d0
gsk.com	TXT	IN	60	Txt: wiz-domain-verification=ec1bffcb8450b6792c1ccded256b4c098d169793814b908c22fbbbd9c60223a5 Entries_0: wiz-domain-verification=ec1bffcb8450b6792c1ccded256b4c098d169793814b908c22fbbbd9c60223a5
gsk.com	TXT	IN	60	Txt: workplace-domain-verification=z80XR6wn7ggP8MBuUTWbCupWiou1uy Entries_0: workplace-domain-verification=z80XR6wn7ggP8MBuUTWbCupWiou1uy

Hosting and Whois Zone

IP	34.117.83.221
Domain infomation	Domain Name: GSK.COM Registry Domain ID: 2466343_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2023-09-21T15:40:09Z Creation Date: 1998-08-07T04:00:00Z Registry Expiry Date: 2024-08-06T04:00:00Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: NS-1070.AWSDNS-05.ORG Name Server: NS-1601.AWSDNS-08.CO.UK Name Server: NS-87.AWSDNS-10.COM Name Server: NS-999.AWSDNS-60.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2024-04-19T02:13:54Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars.